Michael Repka

527 total citations
36 papers, 376 citations indexed

About

Michael Repka is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Repka has authored 36 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Repka's work include Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Prostate Cancer Treatment and Research (9 papers). Michael Repka is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Prostate Cancer Treatment and Research (9 papers). Michael Repka collaborates with scholars based in United States and Germany. Michael Repka's co-authors include Jonathan W. Lischalk, Chao Zhang, Drew M. Lowery, Michael B. Yaffe, Steven A. Carr, Karl R. Clauser, John Maciejowski, Mark E. Burkard, Prasad V. Jallepalli and Kevan M. Shokat and has published in prestigious journals such as PLoS Biology, International Journal of Radiation Oncology*Biology*Physics and American Journal of Ophthalmology.

In The Last Decade

Michael Repka

34 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Repka United States 10 140 129 127 78 70 36 376
Tianzhu Lu China 15 195 1.4× 156 1.2× 17 0.1× 213 2.7× 17 0.2× 59 614
Jaco C. Bleeker Netherlands 14 105 0.8× 44 0.3× 36 0.3× 148 1.9× 10 0.1× 22 407
Luying Xu China 14 91 0.7× 120 0.9× 5 0.0× 137 1.8× 31 0.4× 23 502
Matthew D. Cheney United States 10 253 1.8× 81 0.6× 18 0.1× 61 0.8× 5 0.1× 14 472
Rebeca San Martin United States 7 198 1.4× 84 0.7× 21 0.2× 77 1.0× 2 0.0× 14 353
C. Maschi France 15 83 0.6× 112 0.9× 8 0.1× 201 2.6× 22 0.3× 47 661
Mary Smith United States 7 184 1.3× 17 0.1× 30 0.2× 162 2.1× 10 0.1× 8 352
Jeffrey Kuo United States 6 169 1.2× 63 0.5× 5 0.0× 54 0.7× 29 0.4× 17 359
M. Bremer Germany 10 267 1.9× 138 1.1× 9 0.1× 112 1.4× 8 0.1× 23 466
Jeannette Ossewaarde‐van Norel Netherlands 13 110 0.8× 30 0.2× 74 0.6× 61 0.8× 32 476

Countries citing papers authored by Michael Repka

Since Specialization
Citations

This map shows the geographic impact of Michael Repka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Repka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Repka more than expected).

Fields of papers citing papers by Michael Repka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Repka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Repka. The network helps show where Michael Repka may publish in the future.

Co-authorship network of co-authors of Michael Repka

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Repka. A scholar is included among the top collaborators of Michael Repka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Repka. Michael Repka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijetunga, N. Ari, Krishna Kanchi, Jay A. Moore, et al.. (2024). Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features. Cancer Research Communications. 4(9). 2320–2334. 3 indexed citations
2.
Chen, Xuguang, David J. Sher, Christopher Blake Sullivan, et al.. (2024). Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction. Practical Radiation Oncology. 14(4). 328–333. 1 indexed citations
3.
Repka, Michael, Tamir Sholklapper, Alan Zwart, et al.. (2024). Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in Oncology. 14. 1381134–1381134. 2 indexed citations
4.
Lischalk, Jonathan W., Meredith Akerman, Michael Repka, et al.. (2024). High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation. Frontiers in Oncology. 14. 1325200–1325200.
5.
Repka, Michael, et al.. (2024). Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder Cancer. Bladder Cancer. 10(2). 145–155.
6.
Repka, Michael, Ima Paydar, Binbin Wu, et al.. (2023). Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncologica. 62(2). 174–179. 1 indexed citations
7.
Leu, Justin, Meredith Akerman, Christopher Mendez, et al.. (2023). Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure. Frontiers in Oncology. 13. 1132777–1132777. 3 indexed citations
8.
Repka, Michael, Michael Creswell, Jonathan W. Lischalk, et al.. (2022). Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer. Frontiers in Oncology. 12. 860848–860848. 6 indexed citations
9.
Aghdam, Nima, Haijun Wang, Michael Repka, et al.. (2020). Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non‐small cell lung cancer. Cancer Medicine. 9(15). 5362–5380. 14 indexed citations
10.
Aghdam, Nima, Michael Repka, Ima Paydar, et al.. (2020). Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer. Frontiers in Oncology. 10. 572564–572564. 6 indexed citations
11.
Repka, Michael, et al.. (2020). Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT. Frontiers in Oncology. 10. 203–203. 4 indexed citations
12.
Repka, Michael, Siyuan Lei, L. D. Campbell, et al.. (2018). Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk. Frontiers in Oncology. 8. 373–373. 3 indexed citations
13.
Repka, Michael, et al.. (2017). The Role of Radiotherapy in the Management of Gastric Cancer. 13(5). 2 indexed citations
14.
Repka, Michael, Nima Aghdam, L. D. Campbell, et al.. (2017). Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation. Radiation Oncology. 12(1). 162–162. 16 indexed citations
15.
Lischalk, Jonathan W., Laila König, Michael Repka, et al.. (2016). From Röntgen Rays to Carbon Ion Therapy: The Evolution of Modern Radiation Oncology in Germany. International Journal of Radiation Oncology*Biology*Physics. 96(4). 729–735. 2 indexed citations
16.
Bernhardt, Denise, Sebastian Adeberg, Farastuk Bozorgmehr, et al.. (2016). Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer. Clinical Lung Cancer. 18(4). e267–e271. 13 indexed citations
17.
Lischalk, Jonathan W., Stephanie Woo, Nima Aghdam, et al.. (2016). Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). Journal of Radiation Oncology. 5(4). 379–387. 27 indexed citations
18.
Yamoah, Kosj, Harriet Eldredge-Hindy, Nicholas G. Zaorsky, et al.. (2014). Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13(5). 456–464. 7 indexed citations
19.
Ahmad, Jamal, Michael Repka, & Steven M. Raikin. (2013). Treatment of Myotendinous Achilles Ruptures. Foot & Ankle International. 34(8). 1074–1078. 24 indexed citations
20.
Burkard, Mark E., John Maciejowski, Verónica Rodríguez-Bravo, et al.. (2009). Plk1 Self-Organization and Priming Phosphorylation of HsCYK-4 at the Spindle Midzone Regulate the Onset of Division in Human Cells. PLoS Biology. 7(5). e1000111–e1000111. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianzhu Lu Breakdown of academic impact, for papers by Jaco C. Bleeker Breakdown of academic impact, for papers by Luying Xu Breakdown of academic impact, for papers by Matthew D. Cheney Breakdown of academic impact, for papers by Rebeca San Martin Breakdown of academic impact, for papers by C. Maschi Breakdown of academic impact, for papers by Mary Smith Breakdown of academic impact, for papers by Jeffrey Kuo Breakdown of academic impact, for papers by M. Bremer Breakdown of academic impact, for papers by Jeannette Ossewaarde‐van Norel
Rankless by CCL
2026